1Karas RH. Statin use enhances coronary collaterals[J]. Am Heart J, 2003,146: 876-881.
2Pliquett RU, Cornish KG, Peuler JD, et al. Simvastatin normalizes autonomic neural control in experimental heart failure [J]. Circulation, 2003,107: 2493-2498.
3Grip O, Janciauskiene S, Lindgren S. Pravastatin down-regulates inflammatory mediators in human monocytes in vitro [J]. Eur J Pharmacol, 2000,410: 83-92.
5Maack C, Kartes T, Kilter H, et al. Oxygen free radical release in human failing myocardium is associated with increased activity of racl-GTPase and represents a target for statin treatment[J]. Circulation, 2003,108: 1567-1574.
6Segal R,Fiebeler A,Park JK, et al. Amelioration of angiotensin Ⅱ-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor[J]. Circulation, 2001,104:576-581.
7Node K. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy[J]. Circulation, 2003,108: 839-843.
8Katta M, Alexander BS, Krichten CM, et al. The effect of coenzyme Q10 in patients with congestive heart failure [J]. Ann Intern Med, 2000,132:636-640.
9Rauchhaus M, Clark AL, Doehner W, et al. The relationship between cholesterol and survival in patients with chronic heart failure [J]. J Am Coll Cardiol,2003,42:1933-1940.
10Fonarow G, Horwich TB. Cholesterol and mortality in heart failure: the bad gone good[J]? J Am Coll Cardiol,2003,42: 1941-1943.
